Anti-Xa activity in VTE patients treated with fondaparinux

Clin Chim Acta. 2015 Mar 10:442:22-3. doi: 10.1016/j.cca.2015.01.004. Epub 2015 Jan 10.

Authors

Satoshi Ota¹, Hideo Wada², Akimasa Mastuda¹, Yoshito Ogihara¹, Norikazu Yamada¹, Masio Nakamura¹, Masaaki Ito¹

Affiliations

¹ Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Tsu, Japan.
² Department of Molecular and Laboratory Medicine, Mie University Graduate School of Medicine, Tsu, Japan. Electronic address: [email protected].

PMID: 25584459
DOI: 10.1016/j.cca.2015.01.004

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Aged
Aged, 80 and over
Factor Xa / metabolism*
Factor Xa Inhibitors / pharmacology*
Factor Xa Inhibitors / therapeutic use
Female
Fondaparinux
Humans
Male
Middle Aged
Polysaccharides / pharmacology*
Polysaccharides / therapeutic use
Venous Thromboembolism / drug therapy*

Substances

Factor Xa Inhibitors
Polysaccharides
Factor Xa
Fondaparinux